Invention Grant
- Patent Title: Combination drug
-
Application No.: US17358933Application Date: 2021-06-25
-
Publication No.: US11896579B2Publication Date: 2024-02-13
- Inventor: Hiroshi Sakamoto , Toshiyuki Tsukaguchi
- Applicant: Chugai Seiyaku Kabushiki Kaisha
- Applicant Address: JP Tokyo
- Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP 15007244 2015.01.16
- The original application number of the division: US15543033
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61K45/06 ; A61K31/4545 ; A61K31/506 ; A61K31/5355 ; A61K39/395 ; A61K31/44
Abstract:
The present invention relates to a drug that is for treating or preventing cancer, that is effective in the treatment of cancer, and that comprises a combination of an ALK inhibitor and a VEGF inhibitor. The present invention also relates to a method for treating or preventing cancer and a method for inhibiting tumor growth.
Public/Granted literature
- US20210322380A1 COMBINATION DRUG Public/Granted day:2021-10-21
Information query
IPC分类:
